These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23875862)

  • 1. Risk factors for extensively drug-resistant tuberculosis: a review.
    Flor de Lima B; Tavares M
    Clin Respir J; 2014 Jan; 8(1):11-23. PubMed ID: 23875862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa.
    Andrews JR; Shah NS; Gandhi N; Moll T; Friedland G;
    J Infect Dis; 2007 Dec; 196 Suppl 3():S482-90. PubMed ID: 18181698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Representations of MDR and XDR-TB in South African newspapers.
    Daku M; Gibbs A; Heymann J
    Soc Sci Med; 2012 Jul; 75(2):410-8. PubMed ID: 22534376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Household contact investigation of multidrug-resistant and extensively drug-resistant tuberculosis in a high HIV prevalence setting.
    Vella V; Racalbuto V; Guerra R; Marra C; Moll A; Mhlanga Z; Maluleke M; Mhlope H; Margot B; Friedland G; Shah NS; Gandhi NR
    Int J Tuberc Lung Dis; 2011 Sep; 15(9):1170-5, i. PubMed ID: 21943840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A historical review of XDR tuberculosis in the Western Cape province of South Africa.
    Symons G; Shean K; Pietersen E; Van Zyl Smit R; Pool L; Davids M; Willcox P; Dheda K
    S Afr Med J; 2011 Sep; 101(9):636-8. PubMed ID: 21920174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Provider perspectives on drug-resistant tuberculosis and human immunodeficiency virus care in South Africa: a qualitative case study.
    Daftary A; Padayatchi N
    Int J Tuberc Lung Dis; 2016 Nov; 20(11):1483-1488. PubMed ID: 27776589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotypic diversity of extensively drug-resistant tuberculosis (XDR-TB) in South Africa.
    Mlambo CK; Warren RM; Poswa X; Victor TC; Duse AG; Marais E
    Int J Tuberc Lung Dis; 2008 Jan; 12(1):99-104. PubMed ID: 18173885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and operational value of the extensively drug-resistant tuberculosis definition.
    Migliori GB; Besozzi G; Girardi E; Kliiman K; Lange C; Toungoussova OS; Ferrara G; Cirillo DM; Gori A; Matteelli A; Spanevello A; Codecasa LR; Raviglione MC;
    Eur Respir J; 2007 Oct; 30(4):623-6. PubMed ID: 17690121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensively drug-resistant tuberculosis: new strains, new challenges.
    Banerjee R; Schecter GF; Flood J; Porco TC
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):713-24. PubMed ID: 18847407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [MDR, pre-XDR and XDR drug-resistant tuberculosis in Poland in 2000-2009].
    Kozińska M; Brzostek A; Krawiecka D; Rybczyńska M; Zwolska Z; Augustynowicz-Kopeć E
    Pneumonol Alergol Pol; 2011; 79(4):278-87. PubMed ID: 21678278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality.
    Gandhi NR; Shah NS; Andrews JR; Vella V; Moll AP; Scott M; Weissman D; Marra C; Lalloo UG; Friedland GH;
    Am J Respir Crit Care Med; 2010 Jan; 181(1):80-6. PubMed ID: 19833824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exogenous reinfection as a cause of multidrug-resistant and extensively drug-resistant tuberculosis in rural South Africa.
    Andrews JR; Gandhi NR; Moodley P; Shah NS; Bohlken L; Moll AP; Pillay M; Friedland G; Sturm AW;
    J Infect Dis; 2008 Dec; 198(11):1582-9. PubMed ID: 18847372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug-resistant and extensively drug-resistant tuberculosis: a review.
    Chan ED; Iseman MD
    Curr Opin Infect Dis; 2008 Dec; 21(6):587-95. PubMed ID: 18978526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug and extensively drug-resistant TB (M/XDR-TB): problems and solutions.
    Prasad R
    Indian J Tuberc; 2010 Oct; 57(4):180-91. PubMed ID: 21141336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug- and extensively drug-resistant tuberculosis, Germany.
    Eker B; Ortmann J; Migliori GB; Sotgiu G; Muetterlein R; Centis R; Hoffmann H; Kirsten D; Schaberg T; Ruesch-Gerdes S; Lange C;
    Emerg Infect Dis; 2008 Nov; 14(11):1700-6. PubMed ID: 18976552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extensively drug-resistant tuberculosis in sub-Saharan Africa: an emerging public-health concern.
    Jones KD; Hesketh T; Yudkin J
    Trans R Soc Trop Med Hyg; 2008 Mar; 102(3):219-24. PubMed ID: 18243260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Extensively drug-resistant tuberculosis].
    Lange C; Grobusch MP; Wagner D
    Dtsch Med Wochenschr; 2008 Feb; 133(8):374-6. PubMed ID: 18270922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clofazimine in the treatment of extensively drug-resistant tuberculosis with HIV coinfection in South Africa: a retrospective cohort study.
    Padayatchi N; Gopal M; Naidoo R; Werner L; Naidoo K; Master I; O'Donnell MR
    J Antimicrob Chemother; 2014 Nov; 69(11):3103-7. PubMed ID: 24986495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extensively drug resistant tuberculosis (XDR-TB) in Chest Disease Institute, 1997-2005.
    Chuchottaworn C
    J Med Assoc Thai; 2010 Jan; 93(1):34-7. PubMed ID: 20196408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa.
    Streicher EM; Müller B; Chihota V; Mlambo C; Tait M; Pillay M; Trollip A; Hoek KG; Sirgel FA; Gey van Pittius NC; van Helden PD; Victor TC; Warren RM
    Infect Genet Evol; 2012 Jun; 12(4):686-94. PubMed ID: 21839855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.